Beta-Lactam and Beta-lactamase Inhibitor Market Size, Growth, Trends and Demand 2020 to 2030
The Global Beta-Lactam and Beta-lactamase Inhibitor Market was valued at USD 27.49 billion in 2019 and is predicted to reach USD 34.20 billion by 2030 with a CAGR of 1.9% during the forecast period. Beta-lactam inhibitors are a class of antibiotic agents that have a beta lactam ring in their molecular structure. These antibiotic agents help fight against bacterial infections and protozoa infections by killing the bacteria directly or stopping it from growing. Some examples of Beta lactam inhibitors are penicillin, carbapenem etc. Beta-lactamase inhibitors are a class of drugs that block the activity of the Beta-lactam enzymes and restricts the degradation of Beta-lactam. Access Full Description of this report at:- https://www.nextmsc.com/report/beta-lactam-beta-lactamase-inhibitors-market Top Companies: Abbott Laboratories, Allergan plc. F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc., Merck & Co. Inc. Mylan N.V., Novartis International AG, Pfizer Inc., Sanofi and others